Trickle Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1100)	10/21/2002 4:43:15 PM
From: Jibacoa	Read Replies (1) of 1784

BLUD Made a 52 Wks. H today. The company makes automated instrument and reagent systems for blood transfusions. "Only about 15% of the blood transfusion testing market uses automated systems, according to industry experts. Immucor estimates it has about a 54% market share in that niche. The rest is mostly held by Johnson & Johnson's Ortho Clinical Diagnostics division". "Blood tests aren't cut back when the economy slows down," said John Howard, analyst with TM Capital Corp. "This business should be very recession resistant." biz.yahoo.com It has continued to perform well since my previous comments. siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next